Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?

The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the synthetic pure glucocorticoid dexamethasone was identified as an effective compound for treatment of severe COVID-19. However,...

Full description

Bibliographic Details
Main Authors: Tomoshige Kino, Irina Burd, James H. Segars
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/13/6764
id doaj-b269010448c7450ab13aee02aae1858d
record_format Article
spelling doaj-b269010448c7450ab13aee02aae1858d2021-07-15T15:36:40ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-01226764676410.3390/ijms22136764Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?Tomoshige Kino0Irina Burd1James H. Segars2Laboratory of Molecular and Genomic Endocrinology, Sidra Medicine, Doha 26999, QatarDepartment of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAThe coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the synthetic pure glucocorticoid dexamethasone was identified as an effective compound for treatment of severe COVID-19. However, glucocorticoids are generally harmful for infectious diseases, such as bacterial sepsis and severe influenza pneumonia, which can develop respiratory failure and systemic inflammation similar to COVID-19. This apparent inconsistency suggests the presence of pathologic mechanism(s) unique to COVID-19 that renders this steroid effective. We review plausible mechanisms and advance the hypothesis that SARS-CoV-2 infection is accompanied by infected cell-specific glucocorticoid insensitivity as reported for some other viruses. This alteration in local glucocorticoid actions interferes with undesired glucocorticoid to facilitate viral replication but does not affect desired anti-inflammatory properties in non-infected organs/tissues. We postulate that the virus coincidentally causes glucocorticoid insensitivity in the process of modulating host cell activities for promoting its replication in infected cells. We explore this tenet focusing on SARS-CoV-2-encoding proteins and potential molecular mechanisms supporting this hypothetical glucocorticoid insensitivity unique to COVID-19 but not characteristic of other life-threatening viral diseases, probably due to a difference in specific virally-encoded molecules and host cell activities modulated by them.https://www.mdpi.com/1422-0067/22/13/6764glucocorticoidsglucocorticoid receptor (GR)inflammationinnate immunitysevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2)type I interferons (IFNs)
collection DOAJ
language English
format Article
sources DOAJ
author Tomoshige Kino
Irina Burd
James H. Segars
spellingShingle Tomoshige Kino
Irina Burd
James H. Segars
Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
International Journal of Molecular Sciences
glucocorticoids
glucocorticoid receptor (GR)
inflammation
innate immunity
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
type I interferons (IFNs)
author_facet Tomoshige Kino
Irina Burd
James H. Segars
author_sort Tomoshige Kino
title Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
title_short Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
title_full Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
title_fullStr Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
title_full_unstemmed Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
title_sort dexamethasone for severe covid-19: how does it work at cellular and molecular levels?
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-06-01
description The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the synthetic pure glucocorticoid dexamethasone was identified as an effective compound for treatment of severe COVID-19. However, glucocorticoids are generally harmful for infectious diseases, such as bacterial sepsis and severe influenza pneumonia, which can develop respiratory failure and systemic inflammation similar to COVID-19. This apparent inconsistency suggests the presence of pathologic mechanism(s) unique to COVID-19 that renders this steroid effective. We review plausible mechanisms and advance the hypothesis that SARS-CoV-2 infection is accompanied by infected cell-specific glucocorticoid insensitivity as reported for some other viruses. This alteration in local glucocorticoid actions interferes with undesired glucocorticoid to facilitate viral replication but does not affect desired anti-inflammatory properties in non-infected organs/tissues. We postulate that the virus coincidentally causes glucocorticoid insensitivity in the process of modulating host cell activities for promoting its replication in infected cells. We explore this tenet focusing on SARS-CoV-2-encoding proteins and potential molecular mechanisms supporting this hypothetical glucocorticoid insensitivity unique to COVID-19 but not characteristic of other life-threatening viral diseases, probably due to a difference in specific virally-encoded molecules and host cell activities modulated by them.
topic glucocorticoids
glucocorticoid receptor (GR)
inflammation
innate immunity
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
type I interferons (IFNs)
url https://www.mdpi.com/1422-0067/22/13/6764
work_keys_str_mv AT tomoshigekino dexamethasoneforseverecovid19howdoesitworkatcellularandmolecularlevels
AT irinaburd dexamethasoneforseverecovid19howdoesitworkatcellularandmolecularlevels
AT jameshsegars dexamethasoneforseverecovid19howdoesitworkatcellularandmolecularlevels
_version_ 1721299358377312256